7/30/2021 12:13:25 PM - Gapped up on the prior session and rallied to new all-time highs with volume-driven gains. Pulled back last week retesting support near its 50 DMA line ($611). Reported strong earnings on +187% sales revenues for the Jun '21 quarter versus the year ago period, its 4th very strong comparison with earning growth well above the +25% minimum guideline (C criteria). A downturn in FY '20 earnings from the prior year is a small flaw in its impressive annual earnings (A criteria) history.
7/29/2021 12:09:19 PM - Gapped up today and rallied to a new all-time high. Pulled back last week retesting support near its 50 DMA line ($609). Reported strong earnings on +187% sales revenues for the Jun '21 quarter versus the year ago period, its 4th very strong comparison with earning growth well above the +25% minimum guideline (C criteria). A downturn in FY '20 earnings from the prior year is a small flaw in its impressive annual earnings (A criteria) history.
7/26/2021 11:59:58 AM - Pulled back last week retesting support near its 50 DMA line ($604). Reported earnings +241% on +62% sales revenues for the Mar '21 quarter versus the year ago period, its 3rd strong comparison with earning growth well above the +25% minimum guideline (C criteria). A downturn in FY '20 earnings from the prior year is a small flaw in its impressive annual earnings (A criteria) history.
7/6/2021 12:11:40 PM - Pulling back today testing support near its 50 DMA line ($594). Reported earnings +241% on +62% sales revenues for the Mar '21 quarter versus the year ago period, its 3rd strong comparison with earning growth well above the +25% minimum guideline (C criteria). A downturn in FY '20 earnings from the prior year is a small flaw in its impressive annual earnings (A criteria) history.
6/24/2021 11:59:13 AM - Rebounding toward prior highs after finding support at its 50 DMA line. Reported earnings +241% on +62% sales revenues for the Mar '21 quarter versus the year ago period, its 3rd strong comparison with earning growth well above the +25% minimum guideline (C criteria). A downturn in FY '20 earnings from the prior year is a small flaw in its impressive annual earnings (A criteria) history.
4/29/2021 12:00:18 PM - Reversed into the red after early gains today hitting a new all-time high Reported earnings +241% on +62% sales revenues for the Mar '21 quarter versus the year ago period, its 3rd strong comparison with earning growth well above the +25% minimum guideline (C criteria). The downturn in FY '20 earnings from the prior year is a flaw in its annual earnings (A criteria) history.
3/1/2021 12:29:20 PM - Consolidating near its 50 DMA line which has acted as support. Last noted with caution on 2/04/21 while hitting a new all-time high with a big "breakaway gap" backed by heavy volume - "Bullish action came after it reported earnings +48% on +28% sales revenues for the Dec '20 quarter versus the year ago period, its 2nd strong comparison. Prior quarterly comparisons have not shown strong and steady earning growth above the +25% minimum guideline (C criteria). There was a downturn in FY '20 earnings from the prior year, a flaw in its annual earnings (A criteria) history."
2/4/2021 11:53:52 AM - Hitting a new all-time high with a big "breakaway gap" today backed by heavy volume. Bullish action came after it reported earnings +48% on +28% sales revenues for the Dec '20 quarter versus the year ago period, its 2nd strong comparison. Prior quarterly comparisons have not shown strong and steady earning growth above the +25% minimum guideline (C criteria). There was a downturn in FY '20 earnings from the prior year, a flaw in its annual earnings (A criteria) history.
10/26/2020 12:22:47 PM - Hit a new all-time high with a big "breakaway gap" on 11/22/20 backed by 7 times average volume. Noted bullish action came after it reported earnings +52% on +21% sales revenues for the Sep '20 quarter versus the year ago period. Prior quarterly comparisons have not shown strong and steady earning growth above the +25% minimum guideline (C criteria). Estimates for FY '20 are for a -18% earnings decline from the prior year but improving. Annual earnings (A criteria) growth has been strong and steady.
10/23/2020 12:27:23 PM - Hit a new all-time high with a big "breakaway gap" on the prior session backed by 7 times average volume. Bullish action came after it reported earnings +52% on +21% sales revenues for the Sep '20 quarter versus the year ago period. Prior quarterly comparisons have not shown strong and steady earning growth above the +25% minimum guideline (C criteria). Estimates for FY '20 are for a -23% earnings decline from the prior year. Annual earnings (A criteria) had a slight downturn in FY '15.
7/23/2020 12:11:52 PM - Rebounded toward multi-year highs with recent volume-driven gains. Reported a loss of 35 cents per share versus versus earnings of $1.49 per share on -41% sales revenues for the Jun '20 quarter. Prior quarterly comparisons have not shown strong and steady earning growth above the +25% minimum guideline (C criteria). Estimates for FY '20 are for a -47% earnings decline from the prior year. Annual earnings (A criteria) had a slight downturn in FY '15.
7/15/2020 12:25:59 PM - Rebounding toward multi-year highs with today's 2nd consecutive volume-driven gain. Reported earnings -42% on +0% sales revenues for the Mar '20 quarter versus the year ago period. Prior quarterly comparisons have not shown strong and steady earning growth above the +25% minimum guideline (C criteria). Estimates for FY '20 are for a -45% earnings decline from the prior year. Annual earnings (A criteria) had a slight downturn in FY '15.
10/5/2018 12:22:36 PM - Violated its 50 DMA line ($372) with damaging volume-driven losses this week triggering a technical sell signal. Noted with caution in recent mid-day reports - "Trying to rise from a short late-stage base. Reported earnings +53% on +38% sales revenues for the Jun '18 quarter, marking its 6th consecutive quarterly comparison showing very encouraging sales revenues and earning growth. Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system."
10/4/2018 12:13:54 PM - Retreating from its all-time high and slumping below its 50 DMA line ($372) with today's 3rd consecutive loss. Last noted with caution in the 8/28/18 midday report "Trying to rise from a short late-stage base. Reported earnings +53% on +38% sales revenues for the Jun '18 quarter, marking its 6th consecutive quarterly comparison showing very encouraging sales revenues and earning growth. Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system."
8/28/2018 11:44:20 AM - Reversed into the red today after hitting a new all-time high, trying to rise from a short late-stage base. Reported earnings +53% on +38% sales revenues for the Jun '18 quarter, marking its 6th consecutive quarterly comparison showing very encouraging sales revenues and earning growth. Prior mid-day reports noted - "Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system."
7/26/2018 12:12:33 PM - Pulling back today after recently wedging to new all-time highs. Reported earnings +53% on +38% sales revenues for the Jun '18 quarter, marking its 6th consecutive quarterly comparison showing very encouraging sales revenues and earning growth. Prior mid-day reports noted - "Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system."
5/11/2018 12:22:34 PM - Hitting a new all-time high with today's 7th consecutive gain, rising from a choppy "late stage" base. Reported earnings +98% on +41% sales revenues for the Mar '18 quarter, marking its 5th consecutive quarterly comparison showing very encouraging sales revenues and earning growth rate acceleration. Prior mid-day reports noted - "Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system."
4/26/2018 12:06:45 PM - Recently met resistance near prior highs and retreated below 50 DMA line. Reported earnings +98% on +41% sales revenues for the Mar '18 quarter, marking its 5th consecutive quarterly comparison showing very encouraging sales revenues and earning growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system.
4/19/2018 12:45:46 PM - Gapped down today, pulling back after quiet gains this week challenging its all-time high. Due to report first quarter 2018 financial results on Wednesday, April 25, 2018 after the close of market. Traded above and below its 50 DMA line whikle consolidating since last noted in the 1/31/18 mid-day report - "Reported earnings +100% on +44% sales revenues for the Dec '17 quarter, marking its 4th consecutive quarterly comparison showing very encouraging sales revenues and earning growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system."
1/31/2018 12:39:36 PM - Pulling back from its all-time high with a 3rd consecutive volume-driven loss. Reported earnings +100% on +44% sales revenues for the Dec '17 quarter, marking its 4th consecutive quarterly comparison showing very encouraging sales revenues and earning growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15, a small flaw in its fundamentals under the fact-based investment system.
1/30/2018 12:43:40 PM - Pulling back from its all-time high. Due to report earnings today after the close of market. Volume and volatility often increase near earnings news. Noted with caution in prior mid-day report - "Reported +60% earnings on +38% sales revenues for the Sep '17 quarter, its 2nd quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show encouraging sales revenues and growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
1/29/2018 12:06:53 PM - Pulling back from its all-time high. Due to report earnings on Tuesday, January 30, 2018 after the close of market. Volume and volatility often increase near earnings news. Violated its 50 DMA line then rebounded and wedged into new high territory since last noted with caution in the 12/05/17 mid-day report - "Reported +60% earnings on +38% sales revenues for the Sep '17 quarter, its 2nd quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show encouraging sales revenues and growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
12/5/2017 11:48:55 AM - Abruptly pulled back from its all-time high, testing support at its 50 DMA line ($222). Made gradual progress since noted in the 10/30/17 mid-day report after gapping up for a considerable gain - "Reported +60% earnings on +38% sales revenues for the Sep '17 quarter, its 2nd quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show encouraging sales revenues and growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
11/15/2017 12:21:04 PM - Perched near its all-time high. Made gradual progress since last noted in the 10/30/17 mid-day report after gapping up for a considerable gain - "Reported +60% earnings on +38% sales revenues for the Sep '17 quarter, its 2nd quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show encouraging sales revenues and growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
10/30/2017 12:43:52 PM - Gapped up on the prior session hitting a new all-time high. Reported +60% earnings on +38% sales revenues for the Sep '17 quarter, its 2nd quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show encouraging sales revenues and growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
10/27/2017 12:20:21 PM - Gapped up today hitting a new all-time high. Reported +60% earnings on +38% sales revenues for the Sep '17 quarter, its 2nd quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show encouraging sales revenues and growth rate acceleration. Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
8/17/2017 11:57:41 AM - Retreating from its all-time high. Wedged higher with gains lacking great volume conviction since last noted in the 7/28/17 mid-day report - "Reported +37% earnings on +32% sales revenues for the Jun '17 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
7/28/2017 11:51:50 AM - Gapped up today hitting a new all-time high. Reported +37% earnings on +32% sales revenues for the Jun '17 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
6/12/2017 12:13:39 PM - There was a "negative reversal" on the prior session after hitting a new all-time high. The 5/02/17 mid-day report last cautioned - "Reported +18% earnings on +30% sales revenues for the Mar '17 quarter, its 2nd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
5/2/2017 12:56:01 PM - Gapped up on 4/28/17 rallying with heavy volume for new all-time highs. Reported +18% earnings on +30% sales revenues for the Mar '17 quarter, its 2nd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
5/1/2017 12:47:09 PM - Gapped up on the prior session rallying with heavy volume for new all-time highs. Reported +18% earnings on +30% sales revenues for the Mar '17 quarter, its 2nd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
4/28/2017 12:52:55 PM - Gapped up today, rallying with heavy volume for new all-time highs. Reported +18% earnings on +30% sales revenues for the Mar '17 quarter, its 2nd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
11/8/2016 12:27:26 PM - Rebounding toward its 50 DMA line ($91) which may act as resistance after damaging volume-driven losses. Reported +85% earnings on +34% sales revenues for the Sep '16 quarter, its 4th consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
10/3/2016 12:11:04 PM - Gapped down today and violated its 50 DMA line with a damaging volume-driven loss. The 8/25/16 mid-day report cautioned - "Reported +59% earnings on +29% sales revenues for the Jun '16 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
9/21/2016 12:08:45 PM - Perched near all-time highs, consolidating above support at its 50 DMA line. The 8/25/16 mid-day report last cautioned - "Reported +59% earnings on +29% sales revenues for the Jun '16 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
8/25/2016 12:12:53 PM - Retreating from all-time highs after getting very extended from any sound base. The 8/12/16 mid-day report last cautioned members - "Found support at its 50 DMA line. Reported +59% earnings on +29% sales revenues for the Jun '16 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns."
8/12/2016 12:46:03 PM - Hitting new 52-week and all-time highs, very extended from any sound base. Found support at its 50 DMA line. Reported +59% earnings on +29% sales revenues for the Jun '16 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
8/4/2016 12:28:47 PM - Hitting new 52-week and all-time highs with today's 6th consecutive gain, very extended from any sound base. Found support at its 50 DMA line. Reported +59% earnings on +29% sales revenues for the Jun '16 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15 raising fundamental concerns.
7/29/2016 12:14:27 PM - Hitting new 52-week and all-time highs, very extended from any sound base. Found support at its 50 DMA line. Reported +59% earnings on +29% sales revenues for the Jun '16 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15.
5/6/2016 12:14:05 PM - Hovering near new 52-week and all-time highs. Tested support at its 50 DMA line on 4/29/16 when the mid-day report cautioned members - "Reported +32% earnings on +21% sales revenues for the Mar '16 quarter, but prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15."
5/3/2016 12:22:25 PM - Hovering near new 52-week and all-time highs. Tested support at its 50 DMA line on 4/29/16 when the mid-day report cautioned members - "Reported +32% earnings on +21% sales revenues for the Mar '16 quarter, but prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15."
4/29/2016 12:12:25 PM - Down considerably today, testing its 50 DMA line while abruptly retreating after wedging to a new 52-week high with recent gains lacking great volume conviction. Reported +32% earnings on +21% sales revenues for the Mar '16 quarter, but prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15.
3/17/2016 12:12:05 PM - Gapped down today, abruptly retreating after wedging to a new 52-week high with recent gains lacking great volume conviction. Prior mid-day reports cautioned members - "Reported +25% earnings on +16% sales revenues for the Dec '15 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15."
3/8/2016 12:13:26 PM - Wedged to a new 52-week high with a streak of gains lacking great volume conviction. Prior mid-day reports cautioned members - "Reported +25% earnings on +16% sales revenues for the Dec '15 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15."
2/8/2016 12:07:11 PM - Abruptly retreating below its 50 and 200 DMA lines with today's big loss. Following a gap up gain touching a new 52-week high, the 2/01/16 mid-day report cautioned members - "Reported +25% earnings on +16% sales revenues for the Dec '15 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15."
2/1/2016 12:41:15 PM - Gapped up and hit a new 52-week high with above average volume behind the prior session's big gain. Reported +25% earnings on +16% sales revenues for the Dec '15 quarter, but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '15.
1/13/2015 11:54:32 AM - Perched at its 52-week high with above average volume behind today's 8th consecutive gain. Prior mid-day reports cautioned members - "Reported +12% earnings on +15% sales revenues for the Sep '14 quarter, and fundamental concerns remain. The prior quarterly comparison was also below the +25% minimum earnings guideline (C criteria)."
1/12/2015 12:07:24 PM - Perched at its 52-week high with above average volume behind today's 7th consecutive gain. Prior mid-day reports cautioned members - "Reported +12% earnings on +15% sales revenues for the Sep '14 quarter, and fundamental concerns remain. The prior quarterly comparison was also below the +25% minimum earnings guideline (C criteria)."
1/9/2015 11:58:44 AM - Perched at its 52-week high with above average volume behind today's 6th consecutive gain. The 1/08/15 mid-day report cautioned members - "Reported +12% earnings on +15% sales revenues for the Sep '14 quarter, and fundamental concerns remain. The prior quarterly comparison was also below the +25% minimum earnings guideline (C criteria)."
1/8/2015 12:28:48 PM - Perched near its 52-week high with today's 5th consecutive gain. Reported +12% earnings on +15% sales revenues for the Sep '14 quarter, and fundamental concerns remain. The prior quarterly comparison was also below the +25% minimum earnings guideline (C criteria).
1/24/2014 12:00:21 PM - Down considerably today, abruptly retreating from its 52-week high. Slumping toward its 50 DMA line which defines important near-term support to watch. Prior mid-day reports cautioned members - "Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain as the prior 5 quarterly comparisons were below the +25% minimum earnings guideline (C criteria)."
1/17/2014 12:22:58 PM - Gapped up today hitting a new 52-week high. Recently held its ground near its 50 DMA line while the 1/15/14 mid-day report cautioned members - "Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain as the prior 5 quarterly comparisons were below the +25% minimum earnings guideline (C criteria)."
1/15/2014 12:18:22 PM - Today's gain has it challenging its 52-week high after holding its ground near its 50 DMA line in recent weeks. Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain as the prior 5 quarterly comparisons were below the +25% minimum earnings guideline (C criteria).
1/7/2014 12:18:51 PM - Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Today's 3rd consecutive gain with higher volume has it rallying to new 52-week highs after holding its ground near its 50 DMA line in recent weeks. Prior mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
1/6/2014 11:55:56 AM - Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Considerable gain today with higher volume is challenging its 52-week high after holding its ground near its 50 DMA line in recent weeks. Prior mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
11/14/2013 12:04:11 PM - Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Gapped down today, retreating from its 52-week high after stubbornly holding its ground in recent week. Prior mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
10/21/2013 11:54:45 AM - Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Gapped up on the prior session for a new 52-week high after rebounding above its 50 DMA line on the prior session. Recent mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
10/18/2013 12:10:28 PM - Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Gapped up today for a new 52-week high after rebounding above its 50 DMA line on the prior session. Recent mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
10/14/2013 12:43:11 PM - Recent streak of volume-driven losses led to a slump below its 50 DMA line. The 10/04/13 mid-day report cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
10/11/2013 11:57:19 AM - Recent streak of volume-driven losses led to a slump below its 50 DMA line. The 10/04/13 mid-day report cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
10/4/2013 12:10:16 PM - Gapped down today, retreating from its 52-week high and sinking near it 50 DMA line. The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria).
7/22/2013 12:22:48 PM - The past 4 quarterly comparisons through Mar '13 have been below the +25% minimum earnings guideline (C criteria). Survived and gradually rebounded, reaching new highs last week. Last noted when dropped from the Featured Stocks list on 10/19/12.
10/19/2012 4:34:01 PM - Failed to rebound and edged lower with above average volume today. Based on fundamental and technical concerns it will be dropped from the Featured Stocks list tonight. Gapped down on 10/18/12 for a considerable loss after reporting earnings +4% on +8% sales for the Sep '12 quarter, well below the +25% minimum earnings guideline, and its color code was changed to green. This Medical - Supplies firm built an orderly base above its 50 DMA line and above prior highs in the $36 area, however it slumped under its 50 DMA line since highlighted in yellow with pivot point cited based on its 9/13/12 high plus 10 cents in the 10/17/12 mid-day report (read here) while noted - "Disciplined investors may watch for volume-driven gains above its pivot point which are needed to trigger a new technical buy signal. Last noted in the 7/27/12 mid-day report - 'Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating.'" See the latest FSU analysis for more details an a new annotated graph.
10/18/2012 9:59:10 AM - G - Gapped down today for a considerable loss after reporting earnings +4% on +8% sales for the Sep '12 quarter, well below the +25% minimum earnings guideline, and its color code is changed to green. This Medical - Supplies firm built an orderly base above its 50 DMA line and above prior highs in the $36 area, however it slumped under its 50 DMA line since highlighted in yellow with pivot point cited based on its 9/13/12 high plus 10 cents in the 10/17/12 mid-day report (read here) while noted - "Disciplined investors may watch for volume-driven gains above its pivot point which are needed to trigger a new technical buy signal. Last noted in the 7/27/12 mid-day report - 'Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating.'" See the latest FSU analysis for more details an a new annotated graph.
10/17/2012 6:02:49 PM - Y - Traded lower in after-hours action after reporting preliminary earnings after the close today. Volume and volatility often increase near earnings news. This high-ranked Medical - Supplies firm built an orderly base above its 50 DMA line and above prior highs in the $36 area, however it slumped under its 50 DMA line since highlighted in yellow with pivot point cited based on its 9/13/12 high plus 10 cents in today's earlier mid-day report (read here) while noted - "Disciplined investors may watch for volume-driven gains above its pivot point which are needed to trigger a new technical buy signal. Last noted in the 7/27/12 mid-day report - 'Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating.'" See the latest FSU analysis for more details an a new annotated graph.
10/17/2012 3:18:46 PM - Y - Due to report earnings after the close today, and volume and volatility often increase near earnings news. This high-ranked Medical - Supplies firm built an orderly base above its 50 DMA line and above prior highs in the $36 area, however it slumped under its 50 DMA line since highlighted in yellow with pivot point cited based on its 9/13/12 high plus 10 cents in today's earlier mid-day report (read here) while noted - "Disciplined investors may watch for volume-driven gains above its pivot point which are needed to trigger a new technical buy signal. Last noted in the 7/27/12 mid-day report - 'Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating.'"
10/17/2012 12:08:16 PM - Y - This high-ranked Medical - Supplies firm has built an orderly base above its 50 DMA line and above prior highs in the $36 area. Color code is changed to yellow with pivot point cited based on its 9/13/12 high plus 10 cents. Disciplined investors may watch for volume-driven gains above its pivot point which are needed to trigger a new technical buy signal. Last noted in the 7/27/12 mid-day report - "Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating."
7/27/2012 11:51:29 AM - Hitting a new 52-week high today with a 3rd consecutive gain. Recently rallied back with volume-driven gains after slumping under its 50 DMA line, however the 7/20/12 mid-day report noted - "It has not formed a sound base pattern. Little resistance remains due to overhead supply. Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating."
7/25/2012 12:01:47 PM - Perched within close striking distance of its 52-week high after rallying back above its 50 DMA line with volume-driven gains. The 7/20/12 mid-day report noted - "It has not formed a sound base pattern. Little resistance remains due to overhead supply. Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating."
7/20/2012 12:00:23 PM - Rallying back above its 50 DMA line today with a 2nd consecutive volume-driven gain. It has not formed a sound base pattern. Little resistance remains due to overhead supply. Earnings rose +70% on +21% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking a 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been good following a downturn in FY '08. Patient and disciplined investors may watch for a proper base to form while it continues consolidating.
7/16/2012 11:56:34 AM - Violated its 50 DMA line last week, and today's loss has it slumping near prior lows that define the next important chart support level. Earnings rose +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period, and the Dec '11 period showed strong sales and earnings increases. The 4 previous quarters showed earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08.
7/2/2012 12:00:48 PM - Found support above its 50 DMA line while consolidating. Earnings rose +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period, and the Dec '11 period showed strong sales and earnings increases. The 4 previous quarters showed earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08.
6/22/2012 11:47:30 AM - Pulling back from its 52-week high with above average volume behind a 3rd consecutive loss today after a streak of 6 consecutive gains. The 6/18/12 mid-day report noted - "Rallying from a 'double bottom' base today after finding support near its 50 DMA line during its consolidation since noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08."
6/20/2012 11:56:36 AM - Pulling back from its 52-week high today after 6 consecutive gains. The 6/18/12 mid-day report noted - "Rallying from a 'double bottom' base today after finding support near its 50 DMA line during its consolidation since noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08."
6/19/2012 11:46:27 AM - Hit a new 52-week high with today's 5th consecutive gain. The 6/18/12 mid-day report noted - "Rallying from a 'double bottom' base today after finding support near its 50 DMA line during its consolidation since noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08."
6/18/2012 12:02:01 PM - Rallying from a "double bottom" base today after finding support near its 50 DMA line during its consolidation since noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08.
6/13/2012 11:53:20 AM - Finding support at its 50 DMA line during its consolidation since noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08.
5/22/2012 11:55:06 AM - Found support at its 50 DMA line during its consolidation since last noted when it gapped up on 4/24/12 for a considerable gain and new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08. The Medical - Supplies group has improved (Group RS rating is 90), which is encouraging news concerning the L criteria.
4/24/2012 11:58:22 AM - Gapped up today for a considerable gain, hitting new 52-week and all-time highs. Reported earnings +29% on +29% sales revenues for the quarter ended March 31, 2012 versus the year ago period. The prior quarterly comparison (Dec '11) also showed strong sales and earnings increases following 4 previous quarters with earnings increases below the +25% minimum guideline. Its annual earnings (A criteria) history has been good following a downturn in FY '08. The Medical - Supplies group is currently low ranked (Group RS rating is 38), which is bad news concerning the L criteria.
10/21/2010 12:13:31 PM - Perched at its new 52-week high. In prior mid-day reports it was noted -"Above prior chart highs in the $20 area after the previously noted 7-month cup shaped pattern. Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but its annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked (Group RS rating is 46), which is bad news concerning the L criteria."
10/20/2010 12:57:05 PM - Gapped up today and touched a new 52-week high. While recently consolidating, in prior mid-day reports it was noted -"Above prior chart highs in the $20 area after the previously noted 7-month cup shaped pattern. Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but its annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked (Group RS rating is 47), which is bad news concerning the L criteria."
10/19/2010 12:34:38 PM - Consolidating from its 52-week high above prior chart highs in the $20 area after the previously noted 7-month cup shaped pattern. Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but its annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked (Group RS rating is 48), which is bad news concerning the L criteria.
10/15/2010 12:22:19 PM - Hovering at its 52-week high today, noted in recent mid-day reports before and after gapping up from a near 7-month cup shaped pattern - "Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but it annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked, which is bad news concerning the L criteria."
10/14/2010 12:15:28 PM - Hit another new 52-week high today. Noted in the 2 prior mid-day reports before and after gapping up from a near 7-month cup shaped pattern - "Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but it annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked, which is bad news concerning the L criteria."
10/13/2010 12:08:31 PM - Hit a new 52-week high today after gapping up. Noted in the 10/12/10 mid-day report after a near 7-month cup shaped pattern - "Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but it annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked, which is bad news concerning the L criteria."
10/12/2010 12:29:44 PM - Trading near its 52-week high after a near 7-month cup shaped pattern. Recent quarterly comparisons (C criteria) show strong sales and earnings increases with impressive acceleration, but it annual earnings (A criteria) history has been erratic. The Medical - Supplies group is currently low ranked, which is bad news concerning the L criteria.
4/12/2004 1:00:00 PM - Y - Decent group. Nice move today. Decent last couple of "C"s. "A" improving. Nice "S" & "I".